Purr Podcast

In the 200th episode of the Purr Podcast, Dr. Kelly and Dr. Susan are joined by the esteemed Dr. Thomas Schemerhorn to discuss feline hyperthyroidism, a common condition in older cats. They delve into the four accepted therapies for managing this endocrine disorder, offering insights into each approach's pros and cons. Sponsored by Norbrook, makers of Felanorm (methimazole) oral solution for cats, the episode also highlights the importance of bioequivalent pharmaceutical products in veterinary care. Take advantage of this milestone episode packed with expert advice on keeping hyperthyroid kitties healthy and happy!

Dr. Kelly and Dr. Susan totally rock the intro of this week’s PurrPodcast episode! Their special guest is Dr. Schermerhorn from Kansas State University, an expert in feline endocrinology. Dr. Schermerhorn dives deep into the complexities of diabetes in cats, shedding light on one of the more serious complications—hyperosmolar hyperglycemic state. Together, they discuss the symptoms, diagnostic challenges, and treatment approaches for this condition, offering vital insights for both veterinarians and pet owners. It’s an episode packed with expert knowledge, delivered with their signature energy and enthusiasm!

Dr. Julia Beatty is back with here extra-ordinary story about hepadna viruses in cats.

Hepadnavirus infections in cats are caused by the feline hepadnavirus, a member of the Hepadnaviridae family, which includes viruses like the human hepatitis B virus. Discovered relatively recently, feline hepadnavirus primarily affects the liver. It is thought to contribute to liver disease in cats, such as hepatitis and hepatocellular carcinoma (liver cancer).The virus has a unique life cycle, involving reverse transcription to replicate its DNA. Though not yet fully understood, research suggests that feline hepadnavirus may lead to chronic liver issues in infected cats, similar to hepatitis B in humans. Symptoms may include jaundice, lethargy, weight loss, and gastrointestinal upset, but specific diagnosis requires advanced molecular testing.Treatment focuses on managing liver disease symptoms, as there is no specific antiviral treatment available for this virus in cats yet.

In this podcast episode, we interview Dr. Julia Beatty, a distinguished Professor of Veterinary Medicine and Infectious Diseases at City University’s Jockey Club College of Veterinary Medicine and Life Sciences. Dr. Beatty shares her remarkable journey from studying at University College London and the Royal Veterinary College to her extensive work in feline medicine and infectious diseases. She discusses her career milestones, including her PhD in feline virology at the University of Glasgow, her leadership roles at the University of Sydney, and her contributions to the field through various boards and editorial positions. Dr. Beatty also offers insights into her research, her passion for feline medicine, and the future of veterinary infectious diseases.
Hepatitis B-like viruses (hepadnaviruses) have been identified in a wide range of animals, including cats. The hepadnavirus in cats, sometimes referred to as feline hepadnavirus or FeHBV, is similar to the human hepatitis B virus but is specific to felines.This virus is a relatively recent discovery, and researchers like Dr. Julia Beatty have been at the forefront of studying it. FeHBV has been found in domestic cats, and while the full impact on feline health is still being explored, there is concern that it could contribute to liver disease in cats, much like its human counterpart does in people.The discovery of FeHBV has opened new avenues for research in feline medicine, particularly in understanding liver diseases in cats and the potential for transmission and prevention. As research continues, it may lead to better diagnostic and treatment options for cats affected by this virus.

In this second episode of their podcast, Dr. Jolle Kirpensteijn and Dr. Susan Little featured Dr. Terza Brostoff, DVM, PhD, from the University of California, Davis, to discuss her pioneering research on new medications for feline infectious peritonitis (FIP). Dr. Brostoff detailed the foundational steps in her investigations aimed at developing effective therapeutic options for this devastating disease, which affects cats and is caused by a coronavirus. We have had some exciting developments in therapeutic possibilities lately.

In this episode of their podcast, Dr. Jolle Kirpensteijn and Dr. Susan Little featured Dr. Terza Brostoff, DVM, PhD, from the University of California, Davis, to discuss her pioneering research on new medications for feline infectious peritonitis (FIP). Dr. Brostoff detailed the foundational steps in her investigations aimed at developing effective therapeutic options for this devastating disease, which affects cats and is caused by a coronavirus. The conversation covered the novel approaches explored to combat FIP and how these potential treatments could transform the prognosis for affected cats. Dr. Brostoff emphasized why these new therapeutic options are groundbreaking, offering hope for significant advancements in feline health and veterinary medicine. The podcast provided a comprehensive overview of the current state of FIP research and the promising future of these new medical interventions.

In our recent podcast episode with Dr. Petra Cerna, an expert on feline mycobacteria, we delved into various aspects of this intriguing topic. Dr. Cerna, who trained under Dr. Susan Little, shared her profound motto: persist. We explored regional concerns such as mycobacterium avium in the US and mycobacterium bovis in the UK, where deer and rodents serve as reservoirs. Our discussion covered key points on diagnosis and therapeutic approaches for managing these infections in feline populations.

Dr. Petra Cerna, a multi-talented professional in the fields of veterinary medicine, law, and cat breeding, graces us with her expertise as a guest on "The PurrPodcast." In this episode, we delve into essential discussions on breeding cats and FIP (Feline Infectious Peritonitis) and the complexities surrounding this disease in relation to feline health. Join us as we explore these critical topics with Petra, whose diverse background offers unique insights into the care and well-being of our feline companions.

Topic: New AAFP/ISFM guidelines for chronic NSAID use in cats Part 2

Guest: Dr. Kelly StDenis, renowned veterinarianSummary:

• Discusses signs of chronic pain in cats, often mistaken for normal aging.
• Explains what NSAIDs are and how they can help manage feline pain.
• Dives into the recently released AAFP/ISFM guidelines for the safe and effective use of chronic NSAIDs in cats.
• Provides information for cat owners concerned about their pet's chronic pain.

In the podcast with Dr. Kelly StDenis, she delves into the new guidelines from AAFP regarding the chronic use of NSAIDs in cats. Dr. StDenis discusses the importance of these guidelines in managing feline pain and the potential risks associated with long-term NSAID usage in cats. She provides insights into alternative pain management strategies and emphasizes the need for careful monitoring when using NSAIDs in feline patients.